Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo pharma news

Tag: aurobindo pharma news

Read all Latest developments, information and news on and about Aurobindo Pharmaceuticals - Page 9

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Court sends Aurobindo Pharma Director Sarath Chandra Reddy to judicial custody till 5 December in Delhi Excise Policy case

Ruchika Sharma22 Nov 2022 3:25 PM IST

New Delhi: The Rouse Avenue Court on Monday sent two businessmen to judicial custody in connection with ED's ongoing money laundering probe into the...

Aurobindo Pharma aims to complete Rs 2,000 crore Penicillin G plant in AP by March 2024

Ruchika Sharma22 Nov 2022 11:35 AM IST

According to him, out of Rs 2000 crore, the drug maker has already spent around Rs 500 crore and Rs 1,500 crore is going to be spent in the coming...

Aurobindo Pharma Sangareddy facility gets 10 USFDA observations

Ruchika Sharma20 Nov 2022 3:30 PM IST

Hyderabad: Drugmaker Aurobindo Pharma has recently announced that the United States Food and Drug Administration (USFDA) has concluded an inspection...

Court extends ED remand of Aurobindo Pharma Director till November 21 in Delhi Excise Policy case

Ruchika Sharma19 Nov 2022 3:00 PM IST

New Delhi: The Rouse Avenue Court on Thursday extended the Enforcement Directorate remand till November 21 for two businessmen of Andhra Pradesh and...

Aurobindo Pharma subsidiary bags USFDA nod for Amphotericin B Liposome for Injection

Ruchika Sharma18 Nov 2022 2:30 PM IST

This is a partnership product from TTY Biopharm Company Limited and will be manufactured at their Taiwan facility and marketed by Eugia Pharma.

USFDA issues EIR for Aurobindo Pharma Andhra Pradesh facility

Ruchika Sharma17 Nov 2022 11:32 AM IST

New Delhi: Drugmaker Aurobindo Pharma Ltd has announced that the company has received an Establishment Inspection Report (EIR) from the US Food...

Aurobindo Pharma net profit drops 41 percent to Rs 409 crore in Q2

Ruchika Sharma14 Nov 2022 4:30 PM IST

The drug firm reported 11 percent year-on-year dip in US formulations revenue to Rs 2,638 crore.

Aurobindo Pharma Director arrested in Delhi excise policy money laundering case

Roshni Dhar12 Nov 2022 11:41 AM IST

The whole-time director of pharma company Aurobindo Pharma, Sharath Chandra Reddy has recently been arrested by the Enforcement Directorate (ED) in...

Health Bulletin 11/November/2022

Roshni Dhar11 Nov 2022 5:26 PM IST

Here are the top health news for the day:Beedi worker's daughter clears NEET watching YouTube VideosA beedi worker's daughter, who lost her...

Aurobindo Pharma says Director P Sarath Chandra Reddy arrest no way connected with operations

Ruchika Sharma11 Nov 2022 4:30 PM IST

Sarath Reddy was allegedly instrumental in the cartelisation of licenses and played a role in moving alleged kickbacks in the entire liquor licensing...

Breaking news: Aurobindo Pharma Director arrested in Delhi Excise Policy money laundering case

Ruchika Sharma10 Nov 2022 12:18 PM IST

New Delhi: The whole-time director of pharma company Aurobindo Pharma, Sharath Chandra Reddy has recently been arrested by...

Aurobindo Pharma units recall products in US over manufacturing lapses

Ruchika Sharma8 Nov 2022 11:28 AM IST

The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok